NHC Foods Reports Strong Q3 FY26 Earnings and Plans USD 27 Million Fundraising

NHC Foods Limited reported stronger earnings and fresh fundraising plans after a board meeting on February 9, 2026. The Board cleared unaudited financial statements for Q3 FY26 and the nine months ended December 31, 2025, and backed new borrowing and capital-raising proposals alongside confirmations on earlier issue proceeds utilisation.

The company posted higher standalone and consolidated revenue, along with profit growth supported by better trade volumes and contributions from NHC International L.L.C.-FZ. The Board also agreed to raise funds of up to USD 27 million through multiple instruments and approved an increase in the overall borrowing limit to Rs 500 crore.

For Q3 FY26, NHC Foods recorded standalone revenue from operations of Rs 11,698.09 lakh. This was a strong year-on-year jump from Rs 7,336.53 lakh reported in the quarter ended December 31, 2024. Standalone profit after tax for the December 2025 quarter stood at Rs 187.51 lakh, while nine-month profit reached Rs 489.02 lakh.

On a consolidated basis, revenue from operations for the December 2025 quarter came in at Rs 12,919.04 lakh. Consolidated profit after tax for the quarter was Rs 264.65 lakh. For the nine months ended December 31, 2025, consolidated profit increased to Rs 566.16 lakh, driven by higher trade volumes and performance from subsidiary NHC International L.L.C.-FZ.

The key reported standalone and consolidated financial figures are summarised below for finance readers tracking NHC Foods:

Metric	Period	Amount
Standalone revenue from operations	Q3 FY26	Rs 11,698.09 lakh
Standalone revenue from operations	Q3 FY25	Rs 7,336.53 lakh
Standalone profit after tax	Q3 FY26	Rs 187.51 lakh
Standalone profit after tax	9M FY26	Rs 489.02 lakh
Consolidated revenue from operations	Q3 FY26	Rs 12,919.04 lakh
Consolidated profit after tax	Q3 FY26	Rs 264.65 lakh
Consolidated profit after tax	9M FY26	Rs 566.16 lakh

The Board of Directors also considered and approved "Approved raising of funds through all permitted instruments, including but not limited to, by way of issuance of equity shares (for cash or other than cash)/ convertible bonds/ debentures/ warrants/ preference shares/ foreign currency convertible bond (FCCB) / any other equity linked securities and/ or any other securities including through preferential issue on a private placement basis, qualified institutional placement or any other methods or combinations thereof, listed or unlisted, for an amount not exceeding USD 27 Million (US Dollar 270,00,000) or its equivalent thereof in Indian Rupees or in any other foreign currency (ies), in one or more tranches, inclusive of such premium as may be fixed on such securities at such a time or times, in such a manner and on such terms and Approved raising of funds through all permitted instruments, including but not limited to, by way of issuance of equity shares (for cash or other than cash)/ convertible bonds/ debentures/ warrants/ preference shares/ foreign currency convertible bond (FCCB) / any other equity linked securities and/ or any other securities including through preferential issue on a private placement basis, qualified institutional placement or any other methods or combinations thereof, listed or unlisted, for an amount not exceeding USD 27 Million (US Dollar 270,00,000) or its equivalent thereof in Indian Rupees or in any other foreign currency (ies), in one or more tranches, inclusive of such premium as may be fixed on such securities at such a time or times, in such a manner and on such terms and conditions including security, rate of interest, discount (as permitted under applicable law) etc., as may be deemed appropriate by the Board in its absolute discretion, subject to such approvals as may be required including that of shareholders / regulatory and statutory approvals; conditions including security, rate of interest, discount (as permitted under applicable law) etc., as may be deemed appropriate by the Board in its absolute discretion, subject to such approvals as may be required including that of shareholders / regulatory and statutory approvals," said NHC Foods in a stock exchange filing.

Alongside these new fundraising plans, NHC Foods reported on the utilisation of earlier issue proceeds. The Board reviewed and approved the Statements of Utilization of Proceeds for the Rights Issue and warrants. The company confirmed full deployment of Rs 47.42 crore from the Rights Issue and Rs 8.12 crore from preferential warrants towards specified purposes.

Instrument	Amount	Utilisation details
Rights Issue	Rs 47.42 crore	General business operations, secured loan repayment, working capital, issue expenses
Preferential warrants	Rs 8.12 crore	Working capital, capital expenditure, general corporate purposes

The Board said the Rs 47.42 crore Rights Issue amount was entirely applied towards general business activities, repayment of secured borrowings, additional working capital and costs linked to the issue. Cash inflows of Rs 8.12 crore from the preferential allotment of warrants were used only for working capital needs, capital investments and broader corporate expenditure.

NHC Foods stock performance and NHC Foods financial results

In line with the larger capital structure strategy, the Board also cleared a proposal to raise the company’s borrowing ceiling to Rs 500 crore. Directors further approved a draft postal ballot notice to seek shareholder consent for the new fundraising authorisation and the enhanced borrowing limits, aiming to complete approvals through remote voting.

On the market side, NHC Foods Ltd. (BOM: 517554) closed at Rs 0.79 per share on February 10, 2026. This marked a 2.47% decline from the previous close of Rs 0.81. The stock opened at Rs 0.83, touched an intraday high of Rs 0.83, and slipped to an intraday low of Rs 0.77.

During the same trading session, a total of 3,166,208 NHC Foods shares changed hands on the exchange. The company’s equity market capitalisation stood at Rs 51.96 crore. Over the past twelve months, the share price moved between a high of Rs 1.33 and a low of Rs 0.70, indicating a wide trading range for investors.

The February 9, 2026 board meeting also covered statutory items, including approval of Limited Review Reports from the statutory auditors. The Board adopted the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. These approvals aligned regulatory compliance with the company’s broader funding and growth agenda in the current financial year.